COVID-19: Global Clinical Trial Landscape

COVID-19, caused by the SARS-CoV-2 virus, has profoundly reshaped global healthcare since its emergence in December 2019. A new report takes a look at emerging COVID-19 therapies, trial insights, and innovations shaping the future of global healthcare. Download the free report now to get the latest data-driven insights on current fields of research, including personalised approaches, antivirals such as Paxlovid and Molnupiravir, corticosteroids, and advanced monoclonal antibodies such as sotrovimab.